Picture of ABL Bio logo

298380 ABL Bio Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for ABL Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-37,005-55,606-43,5583,209-2,647
Depreciation
Amortisation
Non-Cash Items9,2139,6258.957,2757,474
Unusual Items
Other Non-Cash Items
Changes in Working Capital2,288-3,37878559,323-35,779
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-23,855-47,295-40,60572,132-28,362
Capital Expenditures-3,839-631-1,266-3,637-5,844
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-4,421-2,99621,487-67,61335,728
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-8,260-3,62720,221-71,25029,884
Financing Cash Flow Items-8.82-12.8-12.4-11.7-1,981
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-47.55982844,6491,437
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-30,888-50,488-19,0703,5472,929